MALIGNANT MELANOMA STAGE IIIC

Clinical trials for MALIGNANT MELANOMA STAGE IIIC explained in plain language.

Never miss a new study

Get alerted when new MALIGNANT MELANOMA STAGE IIIC trials appear

Sign up with your email to follow new studies for MALIGNANT MELANOMA STAGE IIIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New 'Supercharged' immune cell therapy targets Tough-to-Treat melanoma

Disease control Not yet recruiting

This study is testing a new cell therapy called RAPA-201 for people with advanced melanoma that has spread and has stopped responding to standard immunotherapy. Doctors will collect a patient's own immune cells, modify them in a lab to better fight cancer, and then infuse them ba…

Matched conditions: MALIGNANT MELANOMA STAGE IIIC

Phase: PHASE2 • Sponsor: Rapa Therapeutics LLC • Aim: Disease control

Last updated Apr 06, 2026 14:15 UTC

MALIGNANT MELANOMA STAGE IIIC

Get alerted when new MALIGNANT MELANOMA STAGE IIIC trials appear

New 'Supercharged' immune cell therapy targets Tough-to-Treat melanoma